They mimic hormones your gut naturally releases after eating
Elon Musk has spoken openly about using GLP-1s. Weight loss injections can move the scale. They dont build the system that keeps it off. Im not anti weight loss injections. They can suppress appetite. They can reduce weight. They dont teach maintenance. Anyone can lose weight. Keeping it off is the real skill. And that skill is built under pressure. When work is heavy. When sleep is short. When motivation disappears. This is where most people regain. Not because the medication stopped working. But because life restarted. Appetite suppression doesnt build systems. It doesnt create structure. It doesnt change decision making. Most people arent struggling with the drug. Theyre unprepared for life after it. Long term results come from habits that run without effort. Meals you default to. Movement you dont negotiate with. Standards that hold when conditions arent perfect. Your body reflects your daily inputs. Those inputs reflect your identity. This is where coaching actually matters. Not for motivation. Not for discipline speeches. But for aligning behaviour with reality. So progress survives travel, stress, weekends, and real life. If progress only works under perfect conditions, it isnt progress. If youve come off a GLP-1, what determined whether the weight stayed off? - Coach Craig ( Repost for the high performer who needs systems, not shortcuts) Most regain doesnt happen because the drug fails. It happens when a structure is never built underneath it
NAD+ IV Therapy delivers NAD+ directly into the bloodstream, bypassing digestion and providing immediate bioavailability
Microglial and astrocytic proteins are preferentially elevated in the GCLC-KO mouse brain To uncover mechanisms leading to brain atrophy in GCLC-KO mice, we next performed a comprehensive analysis of protein expression by Liquid Chromatography-Mass spectrometry (LCMS) analysis using brain samples from 4-month-old GCLC-KO mice (Fig
Many individuals with type 1 diabetes express frustration with a vicious cycle of increasing insulin doses driving weight gain which requires further increased insulin dose requirements
The FTC and FDA previously collaborated effectively on similar issues, notably in addressing influencer-driven e-cigarette marketing, issuing joint warnings to companies whose influencers failed to properly disclose risks
)
